TLRY Snapshot
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, clinics, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, Germany, Israel, New Zealand, Portugal, Spain, Africa, Switzerland, the United States, Malta, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.
VALUATION DATA
Market Capitalization$4,448,531,968
Price to Sales14.59
Earnings per Share$-1.2300
PE RatioNone
PRICE DATA
Most Recent Close$25.9000
52 Week High$55.01
52 Week Low$2.43
50-Day Moving Average$24.7112
200-Day Moving Average$11.4226
All data are from Alpha Vantage as of today. For more infomation on TLRY see Stock Dividend, Valuation, Price and Financial Data for Investors